Collagen Solutions (LON: COS) isn’t the easiest company to understand. Not only does it operate in the (sometimes) overwhelmingly complicated medical devices industry, but it has also grown via several intricate acquisitions. But now that the company is close to launching its own arthritis product and begins to make more money from high value development agreements, it might be worth taking a closer look. For those looking for more information about this interesting company, chief executive Jamal Rushdy has provided us with a useful low-down.
Register to continue reading this article.
Already a member? Login